[
    [
        {
            "time": "2018-01-12",
            "original_text": "沃森生物业绩变脸巨亏逾5亿 13价肺炎疫苗III期临床试验成功",
            "features": {
                "keywords": [
                    "沃森生物",
                    "业绩变脸",
                    "巨亏",
                    "13价肺炎疫苗",
                    "III期临床试验成功"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物业绩变脸巨亏逾5亿 13价肺炎疫苗III期临床试验成功",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-12",
            "original_text": "沃森生物巨亏逾5亿 13价肺炎疫苗III期临床试验成功",
            "features": {
                "keywords": [
                    "沃森生物",
                    "巨亏",
                    "13价肺炎疫苗",
                    "III期临床试验成功"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物巨亏逾5亿 13价肺炎疫苗III期临床试验成功",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-12",
            "original_text": "沃森生物发布业绩修正公告 大幅下降2017年度利润",
            "features": {
                "keywords": [
                    "沃森生物",
                    "业绩修正",
                    "大幅下降",
                    "2017年度利润"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物发布业绩修正公告 大幅下降2017年度利润",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-12",
            "original_text": "晚间重要公告2018年1月12日星期五",
            "features": {
                "keywords": [
                    "晚间公告",
                    "2018年1月12日"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "晚间重要公告2018年1月12日星期五",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-01-12",
            "original_text": "沃森生物：大幅下修2017年业绩预估，预亏逾5亿元",
            "features": {
                "keywords": [
                    "沃森生物",
                    "大幅下修",
                    "2017年业绩",
                    "预亏",
                    "5亿元"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：大幅下修2017年业绩预估，预亏逾5亿元",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-12",
            "original_text": "沃森生物：大幅下修2017年业绩预估 预亏逾5亿元",
            "features": {
                "keywords": [
                    "沃森生物",
                    "大幅下修",
                    "2017年业绩",
                    "预亏",
                    "5亿元"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：大幅下修2017年业绩预估 预亏逾5亿元",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-12",
            "original_text": "预盈变预亏 沃森生物2017年业绩预告“变脸”",
            "features": {
                "keywords": [
                    "预盈变预亏",
                    "沃森生物",
                    "2017年业绩",
                    "变脸"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "预盈变预亏 沃森生物2017年业绩预告“变脸”",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-12",
            "original_text": "沃森生物：多糖结合疫苗达到临床预设标准，下调业绩预告",
            "features": {
                "keywords": [
                    "沃森生物",
                    "多糖结合疫苗",
                    "临床预设标准",
                    "下调业绩预告"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：多糖结合疫苗达到临床预设标准，下调业绩预告",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-12",
            "original_text": "沃森生物：大幅下调年报预期 预亏5.3亿",
            "features": {
                "keywords": [
                    "沃森生物",
                    "大幅下调",
                    "年报预期",
                    "预亏",
                    "5.3亿"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：大幅下调年报预期 预亏5.3亿",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]